[Research progress of lung cancer on single nuleotide polymorphism].
作者信息
Hua Feng, Zhou Qinghua
机构信息
Shandong Tumor Hospital, Jinan 250117, China.
出版信息
Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):156-64. doi: 10.3779/j.issn.1009-3419.2011.02.10.
Abstract
摘要
相似文献
1
[Research progress of lung cancer on single nuleotide polymorphism].肺癌单核苷酸多态性的研究进展
Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):156-64. doi: 10.3779/j.issn.1009-3419.2011.02.10.
2
MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females.MiR-146a基因多态性与中国非吸烟女性患肺癌风险相关。
Oncotarget. 2017 Jan 10;8(2):2275-2283. doi: 10.18632/oncotarget.13722.
3
[A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].[非小细胞肺癌中CASP9基因的表达及其多态性分布研究]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Feb;24(1):59-62.
4
Regulation of miR-125a expression by rs12976445 single-nucleotide polymorphism is associated with radiotherapy-induced pneumonitis in lung carcinoma patients.rs12976445 单核苷酸多态性对 miR-125a 表达的调控与肺癌患者放疗后放射性肺炎相关。
J Cell Biochem. 2019 Mar;120(3):4485-4493. doi: 10.1002/jcb.27736. Epub 2018 Oct 9.
5
C-reactive protein gene 1846C>T polymorphism is associated with increased risk and clinical features of lung cancer: a case-control study.C反应蛋白基因1846C>T多态性与肺癌风险增加及临床特征相关：一项病例对照研究。
Biosci Rep. 2019 Jun 20;39(6). doi: 10.1042/BSR20181936. Print 2019 Jun 28.
6
[Transcriptome expression analyses of pulmonary renal cell carcinoma metastases].[肺肾细胞癌转移的转录组表达分析]
Urologe A. 2007 Sep;46(9):1291-2. doi: 10.1007/s00120-007-1397-3.
7
A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression.miRNA-135a/b 结合多态性在 CD133 中降低 CD133 表达，从而降低中国人肺癌的风险和改善预后。
Carcinogenesis. 2013 Oct;34(10):2292-9. doi: 10.1093/carcin/bgt181. Epub 2013 May 28.
8
Rs3842530 Polymorphism in MicroRNA-205 Host Gene in Lung and Breast Cancer Patients.肺癌和乳腺癌患者中微小RNA-205宿主基因的Rs3842530多态性
Med Sci Monit. 2016 Nov 25;22:4555-5464. doi: 10.12659/MSM.901042.
9
MicroRNA let-7: Regulation, single nucleotide polymorphism, and therapy in lung cancer.微小RNA let-7：肺癌中的调控、单核苷酸多态性及治疗
J Cancer Res Ther. 2015 Aug;11 Suppl 1:C1-6. doi: 10.4103/0973-1482.163830.
10
Association between NEAT1 polymorphism and the risk of lung cancer: A protocol for systematic review and meta-analysis.NEAT1 多态性与肺癌风险的关联：系统评价和荟萃分析的方案。
Medicine (Baltimore). 2021 Apr 23;100(16):e25478. doi: 10.1097/MD.0000000000025478.
引用本文的文献
1
HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers.基于 HapMap 的研究：CYP2A13 可能是不吸烟人群肺癌发生过程中的潜在关键代谢酶基因。
Thorac Cancer. 2019 Apr;10(4):601-606. doi: 10.1111/1759-7714.12954. Epub 2019 Feb 26.
本文引用的文献
1
[Systematic review of the relationship between family history of lung cancer and lung cancer risk].[肺癌家族史与肺癌风险关系的系统评价]
Zhongguo Fei Ai Za Zhi. 2010 Mar;13(3):224-9. doi: 10.3779/j.issn.1009-3419.2010.03.07.
2
[The next generation sequencing technology and its application in cancer research].[下一代测序技术及其在癌症研究中的应用]
Zhongguo Fei Ai Za Zhi. 2010 Feb;13(2):154-9. doi: 10.3779/j.issn.1009-3419.2010.02.15.
3
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.MDR1 基因单核苷酸多态性与顺铂联合长春瑞滨治疗晚期非小细胞肺癌患者的疗效相关。
Lung Cancer. 2011 Feb;71(2):191-8. doi: 10.1016/j.lungcan.2010.05.005.
4
Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey.土耳其人群中血管紧张素转换酶基因插入/缺失多态性与肺癌的关联
Cancer Genet Cytogenet. 2010 Apr 1;198(1):22-6. doi: 10.1016/j.cancergencyto.2009.11.019.
5
Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients.台湾地区肺癌患者亚甲基四氢叶酸还原酶基因型与吸烟习惯的相互作用。
Cancer Genomics Proteomics. 2009 Nov-Dec;6(6):325-9.
6
ATM polymorphisms and risk of lung cancer among never smokers.ATM 多态性与从不吸烟者肺癌风险的关系。
Lung Cancer. 2010 Aug;69(2):148-54. doi: 10.1016/j.lungcan.2009.11.007. Epub 2009 Dec 11.
7
Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.5p15.33（TERT-CLPTM1L）、6p21.33 和 15q25.1（CHRNA5-CHRNA3）变异与从不吸烟者肺癌风险的关系。
Carcinogenesis. 2010 Feb;31(2):234-8. doi: 10.1093/carcin/bgp287. Epub 2009 Dec 2.
8
hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.HOGG1 Ser326Cys 多态性与肺癌组织学分型风险。
J Hum Genet. 2009 Dec;54(12):739-45. doi: 10.1038/jhg.2009.108. Epub 2009 Oct 30.
9
Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1.15号染色体q24 - 25.1区域肺癌候选易感基因的单倍型及细胞增殖分析
Cancer Res. 2009 Oct 1;69(19):7844-50. doi: 10.1158/0008-5472.CAN-09-1833. Epub 2009 Sep 29.
10
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.血液中 CHRNA3 单核苷酸多态性与晚期非小细胞肺癌患者的预后。
Lung Cancer. 2010 Jun;68(3):491-7. doi: 10.1016/j.lungcan.2009.08.004. Epub 2009 Sep 5.
Zotero 插件